This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Buck Institute for Research on Aging, Napa Therapeutics Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 51 
1 out of 1 Years Active: 2025
Title: Rosalba Perrone: Innovator in CD38 Inhibition
Introduction
Rosalba Perrone is a distinguished inventor based in San Francisco, CA. She has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents. Her innovative work focuses on the inhibition of CD38, a target of interest in various diseases.
Latest Patents
Rosalba holds a patent for "Heteroaryl amide inhibitors of CD38." This patent discloses heteroaryl amide inhibitors of CD38 and outlines methods for making and using these compounds in the treatment of diseases and disorders. Her research has the potential to impact therapeutic strategies significantly.
Career Highlights
Throughout her career, Rosalba has worked with notable organizations, including Napa Therapeutics Limited and the Buck Institute for Research on Aging. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Rosalba has collaborated with esteemed colleagues, including Robert A. Volkmann and Jotham W. Coe. These partnerships have enriched her research and fostered innovation in her field.
Conclusion
Rosalba Perrone is a remarkable inventor whose work on CD38 inhibitors showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options in disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile